Showing results (1321-1330 of 5,058) with videos related to

Sort By:
Pageof 506
Multiple Sclerosis and Related Disorders|August 13, 2015
Continuous prediction of secondary progression in the individual course of multiple sclerosisBengt Skoog, Helen Tedeholm, Björn Runmarker, et al.
Multiple Sclerosis and Related Disorders|August 13, 2015
Outcomes of switching directly to oral fingolimod from injectable therapies: Results of the randomized, open-label, multicenter, Evaluate Patient OutComes (EPOC) study in relapsing multiple sclerosisEdward Fox, Keith Edwards, Gordon Burch, et al.
Multiple Sclerosis and Related Disorders|August 13, 2015
First-dose effects of fingolimod after switching from injectable therapies in the randomized, open-label, multicenter, Evaluate Patient OutComes (EPOC) study in relapsing multiple sclerosisBruce Hughes, Mark Cascione, Mark S Freedman, et al.
Multiple Sclerosis and Related Disorders|August 13, 2015
CD20+inflammatory T-cells are present in blood and brain of multiple sclerosis patients and can be selectively targeted for apoptotic eliminationJanet E Holley, Edwin Bremer, Alexandra C Kendall, et al.
Multiple Sclerosis and Related Disorders|August 13, 2015
P wave duration and dispersion and QT interval in multiple sclerosisNazanin Razazian, Neda Hedayati, Nasrin Moradian, et al.
Multiple Sclerosis and Related Disorders|May 31, 2016
Multiple sclerosis relapses are associated with increased fatigue and reduced health-related quality of life - A post hoc analysis of the TEMSO and TOWER studiesMathias Mäurer, Giancarlo Comi, Mark S Freedman, et al.
Multiple Sclerosis and Related Disorders|May 31, 2016
The Dress: Transforming a web viral event into a scientific surveyMarcello Moccia, Luigi Lavorgna, Roberta Lanzillo, et al.
Multiple Sclerosis and Related Disorders|May 31, 2016
Fingolimod-induced leukoencephalopathy in a patient with neuromyelitis optica spectrum disorderFumihito Yoshii, Yusuke Moriya, Tomohide Ohnuki, et al.
Multiple Sclerosis and Related Disorders|April 12, 2016
Relapses in multiple sclerosis: Relationship to disabilityDouglas S Goodin, Anthony T Reder, Robert A Bermel, et al.
Multiple Sclerosis and Related Disorders|April 12, 2016
Assessing the impact of multiple sclerosis disease activity and daclizumab HYP treatment on patient-reported outcomes: Results from the SELECT trialGlenn Phillips, Shien Guo, Randall Bender, et al.
Pageof 506